Retinal neovascularization in Eales disease

Annals of Ophthalmology

Volumn 35, Issue 1, 2003, Pages 25-27

  Saxena, Sandeep ^a,b   Kumar, Dipak ^b   Maitreya, Amit ^b   Srivastava, Prachi ^b   Khanna, Vinay K ^c   Nath, Rajiv ^b   Seth, P K ^c  

^a River Bank Colony   (India)

^b UNIVERSITY OF LUCKNOW   (India)

^c CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID PEROXIDE; MALONALDEHYDE;

ADOLESCENT; ADULT; ARTICLE; CAPILLARY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EALES DISEASE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; OXIDATIVE STRESS; PERFUSION; RETINA DISEASE; RETINA NEOVASCULARIZATION; THROMBOCYTE; VASCULAR DISEASE; VISUAL IMPAIRMENT;

EID: 0038509168     PISSN: 15304086     EISSN: None     Source Type: Journal    
DOI: 10.1385/AO:35:1:25     Document Type: Article

References (21)

1. Gieser SC, Murphy RP. Eales disease. In: Ryan SJ, ed. Retina. Vol 2. St Louis, Mo: CV Mosby Co; 1994:1503-1508.
2. Atmaca LS, Idil A, Gunduz K. Visualization of retinal vasculitis in Eales disease. Ocular Immunol Inflammol. 1993;1:41-48.
3. Saxena S, Kumar D. Visual outcome of branch retinal vein occlusion in Eales disease. Ann Ophthalmol. 1999;31:173-175.
4. Saxena S, Kumar D. Macular involvement in Eales disease. Ann Ophthalmol. 2000;32:98-100.
5. Kumar D, Saxena RC, Saxena S. Vitreous haemorrhage in Eales disease. Afro-Asian J Ophthalmol. 1995;13:109-12.
6. Saxena S, Kumar D, Singh VK, Rajasingh J. Immunological studies in Eales disease: a review. Afro-Asian J Ophthalmol. 1995;13: 19-22.
7. Saxena S, Rajasingh J, Biswas S, Kumar D, Shinohara T, Singh VK. Cellular immune response to retinal S antigen and interphotoreceptor retinoid binding protein fragments in Eales disease. Pathobiology. 1999;67:37-44.
8. Theodosisadis G. Fluorescein angiography in Eales disease. Am J Ophthalmol. 1970;69:271-277.
9. Stefannsson E. Oxygen and diabetic eye disease. Graefes Arch Clin Exp Ophthalmol. 1990;228:120-123.
10. Saxena S, Khanna VK, Kumar D, Srivastava P, Seth PK. Enhanced oxidative stress in Eales disease. Ann Ophthalmol. 2001;33:40-42.
11. Armstrong D, Hartnett M, Browne R, et al. Lipid-peroxide induced synthesis of cytokine growth factors during neovascularization in the retina. Invest Ophthalmol Vis Sci. 1995;36(suppl 4): 455.
12. Srivastava S, Joshi CS, Sethi PPS, Agrawal AK, Srivastava SK, Seth PK. Altered platelet function in non-insulin dependent diabetes mellitus (NIDDM). Thrombosis Res. 1994;76:451-461.
13. Boehme OH, Kosecki R, Carson S, Stern F, Marks N. Lipoperoxidation in human and rat brain tissue: developmental and regional studies. Brain Res. 1977;136:11-21.
14. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. Arch Ophthalmol. 1986;104:34-41.
15. Central Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. Ophthalmology. 1995;102:1434-1444.
16. Das T, Biswas J, Kumar A, et al. Eales disease. Indian J Ophthalmol. 1994;42:3-18.
17. Casey R, Li WW. Factors controlling ocular angiogenesis. Am J Ophthalmol. 1997;124:521-529.
18. Abraham C, Baig SM, Badrinath SS. Eales disease. Proc All India Ophthalmol Soc. 1977;33:226.
19. Nagpal PN, Sharma RK, Joshi BS, Patel A. Management of Eales disease: analysis of 800 cases (1214 eyes). Asia Pacific J Ophthalmol. 1998;10:11-17.
20. Grattagliano I, Vendemiale G, Boscia F, Micelli-Ferrari T, Cardia L, Altomare E. Oxidative retinal products and ocular damage in diabetic patients. Free Rad Biol Med. 1998;25:369-372.
21. Bhooma V, Sulochana KN, Biswas J, Ramakrishnan S. Eales disease: accumulation of reactive oxygen intermediates and lipid peroxides and decrease of antioxidants causing inflammation, neovascularization and retinal damage. Curr Eye Res. 1997;16: 91-95.